Detalhe da pesquisa
1.
Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent.
Blood
; 128(14): 1845-1853, 2016 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27531676
2.
Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.
J Immunol
; 194(7): 3180-90, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25725100
3.
Targeting transcription factors: promising new strategies for cancer therapy.
Curr Opin Oncol
; 25(6): 652-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24048019
4.
The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.
Blood Adv
; 2(23): 3428-3442, 2018 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30504235
5.
Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia.
Oncotarget
; 7(29): 46301-46314, 2016 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27317770
6.
Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.
Mol Cancer Ther
; 13(5): 1194-205, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24435449
7.
JAK2-STAT5 signaling: A novel mechanism of resistance to targeted PI3K/mTOR inhibition.
JAKSTAT
; 2(4): e24635, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24470973